The Patent Finder

Ensemble Therapeutics Corporation

Also on record
Records under this name other than patents Ensemble Therapeutics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Ensemble Therapeutics Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,605,022Macrocyclic compounds for inhibition of inhibitors of apoptosis
Lapsed on the fee record
Ended Mar 28, 2021 · USPTO record
Lapsed on the fee recordEnded Mar 28, 2021USPTO record
US 9,284,283Macrocyclic compounds for modulating IL-17
Lapsed on the fee record
Ended Mar 15, 2020 · USPTO record
Lapsed on the fee recordEnded Mar 15, 2020USPTO record
US 7,968,289Turn over probes and use thereof for nucleic acid detection
Lapsed on the fee record
Ended Jun 28, 2019 · USPTO record
Lapsed on the fee recordEnded Jun 28, 2019USPTO record
US 8,338,565Macrocyclic compounds for inhibition of tumor necrosis factor alpha
Lapsed on the fee record
Ended Dec 25, 2016 · USPTO record
Lapsed on the fee recordEnded Dec 25, 2016USPTO record
US 8,071,388Compositions and methods for biodetection by nucleic acid-templated chemistry
Lapsed on the fee record
Ended Dec 6, 2015 · USPTO record
Lapsed on the fee recordEnded Dec 6, 2015USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited